Clinical Employee Rotational Program (CERP) – Advisor at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Graduate degree in life sciences, pharmaceutical sciences or equivalent field
Expected graduation by August 2026
Team player with excellent communication skills
Previous laboratory or pharmaceutical research experience in one or more of: Clinical Trial Planning and Design, Clinical Trial Investigator Selection and Oversight, Patient Recruitment and Enrollment, Clinical Diagnostic and Laboratory Science, Clinical Statistics, Data Analysis & Data Management, Clinical Systems Management, Medical Writing, Communication and Documentation, Clinical Supply and Delivery, Clinical Trial Budgeting and Financial Management, or Clinical Research Training and Education

Responsibilities

Clinical Trial Planning and Design
Clinical Trial Investigator Selection and Oversight
Patient Recruitment and Enrollment
Clinical Diagnostic and Laboratory Science
Clinical Statistics, Data Analysis & Data Management
Clinical Systems Management
Medical Writing, Communication and Documentation
Clinical Supply and Delivery
Clinical Trial Budgeting and Financial Management
Clinical Research Training and Education
Actively contribute to CDDA organizational goals through assigned projects
Build comprehensive understanding of the pharmaceutical industry and Eli Lilly's role in delivering innovative medicines

Skills

Clinical Trials

Patient Recruitment

Clinical Statistics

Data Analysis

Data Management

Medical Writing

Clinical Supply

Budgeting

Clinical Research

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free